IT1243342B - ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES - Google Patents

ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES

Info

Publication number
IT1243342B
IT1243342B IT02094490A IT2094490A IT1243342B IT 1243342 B IT1243342 B IT 1243342B IT 02094490 A IT02094490 A IT 02094490A IT 2094490 A IT2094490 A IT 2094490A IT 1243342 B IT1243342 B IT 1243342B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
oral pharmaceutical
inflammatory activities
liquid anti
inflammatory
Prior art date
Application number
IT02094490A
Other languages
Italian (it)
Other versions
IT9020944A1 (en
IT9020944A0 (en
Inventor
Ubaldo Conte
Original Assignee
Farcon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farcon Ag filed Critical Farcon Ag
Publication of IT9020944A0 publication Critical patent/IT9020944A0/en
Priority to IT02094490A priority Critical patent/IT1243342B/en
Priority to DE1991911791 priority patent/DE491897T1/en
Priority to CA002066731A priority patent/CA2066731A1/en
Priority to ES199191911791T priority patent/ES2034926T1/en
Priority to PCT/EP1991/001245 priority patent/WO1992000725A1/en
Priority to EP91911791A priority patent/EP0491897A1/en
Priority to AU80935/91A priority patent/AU8093591A/en
Publication of IT9020944A1 publication Critical patent/IT9020944A1/en
Priority to GR930300021T priority patent/GR930300021T1/el
Application granted granted Critical
Publication of IT1243342B publication Critical patent/IT1243342B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT02094490A 1990-07-13 1990-07-13 ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES IT1243342B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT02094490A IT1243342B (en) 1990-07-13 1990-07-13 ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
PCT/EP1991/001245 WO1992000725A1 (en) 1990-07-13 1991-07-04 Liquid oral pharmaceutical compositions having anti-inflammatory activity
CA002066731A CA2066731A1 (en) 1990-07-13 1991-07-04 Liquid oral pharmaceutical compositions having anti-inflammatory activity
ES199191911791T ES2034926T1 (en) 1990-07-13 1991-07-04 LIQUID ORAL PHARMACEUTICAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTIVITY.
DE1991911791 DE491897T1 (en) 1990-07-13 1991-07-04 LIQUID ANTI-FLAMMABLE MEDICINAL PRODUCTS.
EP91911791A EP0491897A1 (en) 1990-07-13 1991-07-04 Liquid oral pharmaceutical compositions having anti-inflammatory activity
AU80935/91A AU8093591A (en) 1990-07-13 1991-07-04 Liquid oral pharmaceutical compositions having anti-inflammatory activity
GR930300021T GR930300021T1 (en) 1990-07-13 1993-04-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02094490A IT1243342B (en) 1990-07-13 1990-07-13 ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES

Publications (3)

Publication Number Publication Date
IT9020944A0 IT9020944A0 (en) 1990-07-13
IT9020944A1 IT9020944A1 (en) 1992-01-13
IT1243342B true IT1243342B (en) 1994-06-10

Family

ID=11174427

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02094490A IT1243342B (en) 1990-07-13 1990-07-13 ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES

Country Status (7)

Country Link
EP (1) EP0491897A1 (en)
AU (1) AU8093591A (en)
CA (1) CA2066731A1 (en)
ES (1) ES2034926T1 (en)
GR (1) GR930300021T1 (en)
IT (1) IT1243342B (en)
WO (1) WO1992000725A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552160A (en) * 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
WO1993025190A1 (en) * 1992-06-10 1993-12-23 Eastman Kodak Company Surface modified nsaid nanoparticles
JPH07506839A (en) * 1992-12-04 1995-07-27 メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド Sprayable analgesic compositions and methods of use thereof
WO1994028936A1 (en) * 1993-06-08 1994-12-22 Ciba-Geigy Ag Process for the preparation of an oral solid dosage form containing diclofenac
KR100304064B1 (en) * 1993-08-12 2001-11-22 다카하시 미치나오 Oral composition
GB9318880D0 (en) * 1993-09-11 1993-10-27 Smithkline Beecham Plc Pharmaceutical composition
IL111184A (en) * 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
EP0839029A1 (en) * 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
HUP9600758A2 (en) * 1996-03-27 1998-03-02 Cyclolab Ciklodextrin Kutato F Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
DE19651055B4 (en) * 1996-12-09 2006-03-16 Beiersdorf Ag Cosmetic and dermatological sunscreen formulations containing triazine derivatives and dimethyl isosorbide and their use
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
ES2171110B1 (en) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas PHARMACEUTICAL COMPOSITION BASED ON IBUPROFEN AND PROCEDURE FOR PREPARATION.
ITMI20020986A1 (en) * 2002-05-10 2003-11-10 Acraf COMPOSITION BASED ON DICLOFENAC FOR THE TOPICAL TREATMENT OF AFFECTIONS OF THE OROPHARINGOUS CABLE
CA2521603A1 (en) * 2003-04-07 2004-10-21 Jurox Pty Ltd Stable carprofen composition
FR2865648B1 (en) 2004-02-03 2006-06-30 Philippe Perovitch METHOD FOR DIFFUSION OF INSOLUBLE MOLECULES IN AQUEOUS MEDIUM AND COMPOSITION IMPLEMENTING SAID METHOD
KR20170123724A (en) 2006-03-28 2017-11-08 자블린 파머슈티칼스 인코포레이티드 Formulations of low dose diclofenac and beta-cyclodextrin
ES2347754B8 (en) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A ORAL SUSPENSION OF IBUPROPHENE LISINATE
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
SG11202003512YA (en) * 2017-11-30 2020-05-28 Acraf Stable liquid composition of ketoprofen, salts and enantiomers thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (en) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg TRANSDERMALLY RESORBABLE, WATER-BASED PREPARATIONS OF ARYLPROPIONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
BE1000381A4 (en) * 1987-03-13 1988-11-16 Pharlyse Sa PHARMACEUTICAL PREPARATION BASED indomethacin.
IT1223343B (en) * 1987-11-03 1990-09-19 Also Lab Sas PHARMACEUTICAL FORMULATIONS FOR TRANSDERMAL ADMINISTRATION

Also Published As

Publication number Publication date
CA2066731A1 (en) 1992-01-14
WO1992000725A1 (en) 1992-01-23
IT9020944A1 (en) 1992-01-13
GR930300021T1 (en) 1993-04-28
EP0491897A1 (en) 1992-07-01
IT9020944A0 (en) 1990-07-13
ES2034926T1 (en) 1993-04-16
AU8093591A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
IT1243342B (en) ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
IT8220073A0 (en) COMPOUND WITH ANALGESIC, ANTI-INFLAMMATORY AND MUCOREGULATORY ACTIVITIES, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
ITRM910696A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION.
ITMI921123A0 (en) ORAL PHARMACEUTICAL FORMULATIONS CONTAINING ANTHOCYANOSIDS
ITTO920303A0 (en) "ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION"
ITMI930582A0 (en) PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY
ITMI931325A0 (en) PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY
IT1290797B1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS
ITMI913510A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH-BIOAVAILABILITY PROGESTERONE
FI952377A0 (en) Pharmaceutical ibuprofen compositions
IT9019422A0 (en) PHARMACEUTICAL COMPOSITIONS WITH DEPIGMENTING AND "ANTIPHOTOAGING" ACTIVITIES
IT1222867B (en) PHTHALAZIN DERIVED FROM PHARMACEUTICAL ACTIVITIES
IT8219215A0 (en) COMPOUND WITH ANALGESIC, ANTI-INFLAMMATORY AND MUCOREGULATORY ACTIVITIES, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
IT1243702B (en) COMPOUNDS WITH NOOTROP ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
IT1190942B (en) COMPOUND WITH ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY, ITS PREPARATION PROCEDURE AND RELATED PHARMACEUTICAL COMPOSITIONS
ITMI911380A1 (en) COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITIES AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
IT9019701A0 (en) SALTS WITH ANTI-INFLAMMATORY, ANTISEPTIC, DETERGENT AND PHARMACEUTICAL COMPOSITIONS
ITMI911344A1 (en) PHARMACEUTICAL ASSOCIATION WITH ANTINEOPLASTIC ACTIVITIES
IT8221905A0 (en) COMPOUND WITH ANALGESIC, ANTIPYRETIC, ANTI-INFLAMMATORY AND MIORELAXANT ACTIVITIES, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
ITMI911065A1 (en) SALTS WITH ANTI-INFLAMMATORY, ANTISEPTIC, DETERGENT AND PHARMACEUTICAL COMPOSITIONS
IT1290840B1 (en) PHARMACEUTICAL COMPOSITIONS SPRAY FOR THE APPLICATION OF FORMULAS FOR TOPICAL USE CONTAINING ESCINA
IT1276707B1 (en) PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC ACTIVITY
ITRM920045A0 (en) PHARMACEUTICAL COMPOSITIONS WITH ANTI-AGING ACTIVITIES.
ITMI921749A1 (en) HYDROPHILIC PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY ACTIVITY
ITMI921252A0 (en) PHARMACEUTICAL COMPOSITION WITH ANTICOUGH ACTIVITY

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970729